Psychiatry Research: Neuroimaging
Volume 163, Issue 1 , Pages 30-39 , 30 May 2008

Proton magnetic resonance spectroscopy in youth with severe mood dysregulation

  • Daniel P. Dickstein

      Affiliations

    • Unit on Bipolar Spectrum Disorders, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • E.P. Bradley Hospital, East Providence, RI, USA
    • Warren Alpert Medical School of Brown University, Providence, RI, USA
    • Corresponding Author InformationCorresponding author. Bradley/Hasbro Children's Research Center, 1 Hoppin Street, Coro West Rm 2.056, Providence RI 02903, USA. Tel.: +1 401 793 8028; fax: +401 444 8742.
    • ,
  • Jan Willem van der Veen

      Affiliations

    • Magnetic Resonance Spectroscopy Core, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • ,
  • Lisa Knopf

      Affiliations

    • Unit on Bipolar Spectrum Disorders, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • Emotion and Development Branch, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • ,
  • Kenneth E. Towbin

      Affiliations

    • Unit on Bipolar Spectrum Disorders, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • Emotion and Development Branch, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • ,
  • Daniel S. Pine

      Affiliations

    • Emotion and Development Branch, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • ,
  • Ellen Leibenluft

      Affiliations

    • Unit on Bipolar Spectrum Disorders, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA
    • Emotion and Development Branch, Division of Intramural Research Programs, National Institute of Mental Health, Bethesda, MD, USA

Received 22 March 2007 ,Revised 11 September 2007 ,Accepted 19 November 2007.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders 4th Edition Text Revision (DSM-IV-TR). Washington, D.C.: APA; 2000;
  2. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature. 1989;341:197–205
  3. Brotman MA, Schmajuk M, Rich BA, Dickstein DP, Guyer AE, Costello EJ, et al. Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. Biological Psychiatry. 2006;60:991–997
  4. Carlson GA. Mania and ADHD: comorbidity or confusion. Journal of Affective Disorders. 1998;51:177–187
  5. Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, et al. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clinical Neuropharmacology. 2003;26:218–221
  6. Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 2007;17:11–17
  7. Castillo M, Kwock L, Courvoisie H, Hooper SR. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. American Journal of Neuroradiology. 2000;21:832–838
  8. Cecil KM, DelBello MP, Sellars MC, Strakowski SM. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. Journal of Child and Adolescent Psychopharmacology. 2003;13:545–555
  9. Chang K, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry. 2003;53:1059–1065
  10. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. Journal of Neuropsychiatry and Clinical Neurosciences. 2004;16:63–69
  11. Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, et al. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology. 2001;24:359–369
  12. Davanzo P, Yue K, Thomas MA, Belin T, Mintz J, Venkatraman TN, et al. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. American Journal of Psychiatry. 2003;160:1442–1452
  13. DelBello MP, Cecil KM, Adler CM, Daniels JP, Strakowski SM. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology. 2006;31:1264–1273
  14. Dickstein DP, Rich BA, Binstock AB, Pradella AG, Towbin KE, Pine DS, et al. Comorbid anxiety in phenotypes of pediatric bipolar disorder. Journal of Child and Adolescent Psychopharmacology. 2005;15:534–548
  15. Dickstein DP, Nelson EE, McClure EB, Grimley ME, Knopf L, Brotman MA, et al. Cognitive flexibility in phenotypes of pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:341–355
  16. Emslie GJ, Weinberg WA, Rush AJ, Adams RM, Rintelmann JW. Depressive symptoms by self-report in adolescence: phase I of the development of a questionnaire for depression by self-report. Journal of Child Neurology. 1990;5:114–121
  17. Farchione TR, Moore GJ, Rosenberg DR. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biological Psychiatry. 2002;52:86–92
  18. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magnetic Resonance in Medicine. 2006;55:1219–1226
  19. Geller B, Williams M, Zimerman B, Frazier J, Beringer L, Warner KL. Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. Journal of Affective Disorders. 1998;51:81–91
  20. Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Molecular Psychiatry. 2004;9:734–755
  21. Hancu I, Blezek DJ, Dumoulin MC. Automatic repositioning of single voxels in longitudinal 1H MRS studies. NMR in Biomedicine. 2005;18:352–361
  22. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:980–988
  23. Komoroski RA, Kotrla KJ, Lemen L, Lindquist D, Diaz P, Foundas A. Brain metabolite concentration ratios in vivo: multisite reproducibility by single-voxel 1H MR spectroscopy. Magnetic Resonance Imaging. 2004;22:721–725
  24. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Archives of General Psychiatry. 1982;39:879–883
  25. Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. American Journal of Psychiatry. 2003;160:430–437
  26. Lenroot RK, Gogtay N, Greenstein DK, Wells EM, Wallace GL, Clasen LS, et al. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage. 2007;36:1065–1073
  27. MacMaster FP, Carrey N, Sparkes S, Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biological Psychiatry. 2003;53:184–187
  28. Mirza Y, Tang J, Russell A, Banerjee SP, Bhandari R, Ivey J, et al. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:341–348
  29. Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl-Bevacqua J, et al. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. American Journal of Psychiatry. 1999;156:1902–1908
  30. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biological Psychiatry. 2000;48:1–8
  31. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. American Journal of Psychiatry. 2006;163:316–318
  32. NIMH . National Institute of Mental Health research roundtable on prepubertal bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:871–878
  33. O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH. Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain. European Neuropsychopharmacology. 2003;13:199–207
  34. Patel NC, DelBello MP, Cecil KM, Adler CM, Bryan HS, Stanford KE, et al. Lithium treatment effects on myo-inositol in adolescents with bipolar depression. Biological Psychiatry. 2006;60:998–1004
  35. Pogge DL, Wayland-Smith D, Zaccario M, Borgaro S, Stokes J, Harvey PD. Diagnosis of manic episodes in adolescent inpatients: structured diagnostic procedures compared to clinical chart diagnoses. Psychiatry Research. 2001;101:47–54
  36. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  37. Reich W, Neuman RJ, Volk HE, Joyner CA, Todd RD. Comorbidity between ADHD and symptoms of bipolar disorder in a community sample of children and adolescents. Twin Research and Human Genetics. 2005;8:459–466
  38. Rich BA, Schmajuk M, Perez-Edgar KE, Fox NA, Pine DS, Leibenluft E. Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation. American Journal of Psychiatry. 2007;164:309–317
  39. Rosenberg DR, MacMaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, et al. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biological Psychiatry. 2005;58:700–704
  40. Sassi RB, Stanley JA, Axelson D, Brambilla P, Nicoletti MA, Keshavan MS, et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. American Journal of Psychiatry. 2005;162:2109–2115
  41. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, et al. A children's global assessment scale (CGAS). Archives of General Psychiatry. 1983;40:1228–1231
  42. Silverstone PH, Hanstock CC, Fabian J, Staab R, Allen PS. Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biological Psychiatry. 1996;40:235–246
  43. Silverstone PH, McGrath BM, Kim H. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disorders. 2005;7:1–10
  44. Silverstone PH, O'Donnell T, Ulrich M, Asghar S, Hanstock CC. Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study. Human Psychopharmacology. 2002;17:425–429
  45. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Human Psychopharmacology. 2002;17:321–327
  46. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. International Clinical Psychopharmacology. 2003;18:73–79
  47. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry. 2005;10:900–919
  48. Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology. 1995;46:531–540
  49. Werry JS, Sprague RL, Cohen MN. Conners' Teacher Rating Scale for use in drug studies with children—an empirical study. Journal of Abnormal Child Psychology. 1975;3:217–229
  50. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry. 1978;133:429–435
  51. Zarate CA, Quiroz J, Payne J, Manji HK. Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders. Psychopharmacology Bulletin. 2002;36:35–83

PII: S0925-4927(07)00233-8

doi: 10.1016/j.pscychresns.2007.11.006

Psychiatry Research: Neuroimaging
Volume 163, Issue 1 , Pages 30-39 , 30 May 2008

Article Tools

* Image Usage & Resolution